Atom Investors LP Abbott Laboratories Transaction History

Atom Investors LP

$758 Million
Q4 2024

A detailed history of Atom Investors LP transactions in Abbott Laboratories stock. As of the latest transaction made, Atom Investors LP holds 36,222 shares of ABT stock, worth $4.82 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

36,222

Previous 43,558 16.84%

Holding current value

$4.82 Million

Previous $4.97 Million 17.5%

% of portfolio

0.54%

Previous 0.55%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$111.93 - $119.39 $821,118 - $875,845	-7,336 Reduced 16.84%	36,222 $4.1 Million
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $5.86 Million - $6.91 Million	-58,531 Reduced 57.33%	43,558 $4.97 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $3.4 Million - $3.8 Million	33,773 Added 49.44%	102,089 $10.6 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $2.72 Million - $3 Million	24,832 Added 57.11%	68,316 $7.76 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $1.54 Million - $1.89 Million	17,075 Added 64.66%	43,484 $4.79 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $1.01 Million - $1.21 Million	10,590 Added 66.94%	26,409 $2.56 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $1.59 Million - $1.78 Million	15,819 New	15,819 $1.72 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $1.79 Million - $2.62 Million	-28,554 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $14,445 - $16,081	184 Added 0.65%	28,554 $2.48 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $705,297 - $764,761	-8,618 Reduced 23.3%	28,370 $2.37 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $2.7 Million - $3.14 Million	36,988 New	36,988 $3.11 Million

Others Institutions Holding ABT

# of Institutions

3,359

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $233B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.

Account

Atom Investors LP Abbott Laboratories Transaction History